- Institution: Stanford Univ Med Ctr Lane Med Lib/Periodical Dept/Rm L109
- Sign In as Member / Individual
SEROTONIN 5-HT2C RECEPTOR AGONISTS: POTENTIAL FOR THE TREATMENT OF OBESITY
Figure 4.
Diverse chemotypes under investigation as selective 5-HT receptor ligands. The development of highly selective 5-HT2C agonists continues to be challenging, although selectivity of certain compounds indicates that specific receptor subtypes may be targeted in anti-obesity drug development.
